injection largely depends on personal preference
The article explores alternative molecular mechanismsincluding tau protein aggregation, neuroinflammation, synaptic and mitochondrial dysfunction, brain insulin resistance, vascular impairment, and infectious triggersthat may provide better insights into disease progression and resistance to current treatments
as the first therapy to help people manage their weight and reduce cardiovascular risks, Martin Holst Lange, executive vice president and head of development at Novo Nordisk, told the WSJ
Nausea, vomiting, diarrhea, and constipation were all more common at higher doses, though these effects typically diminished after the body adapted to each new dose level